Alan Spatz
McGill University Health Centre · 396 works · 13,902 citations · h-index 59
Top works
- Cutaneous side-effects of kinase inhibitors and blocking antibodies
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
- Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
- EORTC 18961: Post-operative adjuvant ganglioside GM2-KLH21 vaccination treatment vs observation in stage II (T3-T4N0M0) melanoma: 2nd interim analysis led to an early disclosure of the results
- Cutaneous melanoma
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
- Value of high-frequency US for preoperative assessment of skin tumors.
- Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
- Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase Inhibitor
- Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects
- Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
- Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of HRAS , TP53 , and TGFBR1
- Factors to keep in mind when introducing virtual microscopy
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012
- Dermatologic symptoms associated with the multikinase inhibitor sorafenib
- The development of optimal pathological assessment of sentinel lymph nodes for melanoma
- Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas